Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients

被引:16
作者
Chow, Jonathan H. [1 ]
Wittwer, Erica D. [2 ]
Wieruszewski, Patrick M. [2 ]
Khanna, Ashish K. [3 ,4 ]
机构
[1] George Washington Univ, Anesthesiol & Crit Care Med, Sch Med, Washington, DC USA
[2] Mayo Clin, Anesthesiol & Crit Care Med, Sch Med, Rochester, MN USA
[3] Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Sect Crit Care Med, Winston Salem, NC 27157 USA
[4] Outcomes Res Consortium, Cleveland, OH USA
关键词
angiotensin II; shock; postcardiopulmonary bypass vasoplegia; EXTRACORPOREAL MEMBRANE-OXYGENATION; CARDIAC-SURGERY; TISSUE-PERFUSION; RENIN; SHOCK; ANTICOAGULATION; PROGNOSIS;
D O I
10.1016/j.jtcvs.2021.02.097
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1407 / 1414
页数:8
相关论文
共 38 条
  • [1] Angiotensin II in ECMO patients: a word of caution
    Antonucci, Elio
    Taccone, Fabio Silvio
    [J]. CRITICAL CARE, 2019, 23 (1):
  • [2] Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock A Clinical Trial
    Bellomo, Rinaldo
    Forni, Lui G.
    Busse, Laurence W.
    McCurdy, Michael T.
    Ham, Kealy R.
    Boldt, David W.
    Hastbacka, Johanna
    Khanna, Ashish K.
    Albertson, Timothy E.
    Tumlin, James
    Storey, Kristine
    Handisides, Damian
    Tidmarsh, George F.
    Chawla, Lakhmir S.
    Ostermann, Marlies
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (09) : 1253 - 1261
  • [3] Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
    Bellomo, Rinaldo
    Wunderink, Richard G.
    Szerlip, Harold
    English, Shane W.
    Busse, Laurence W.
    Deane, Adam M.
    Khanna, Ashish K.
    McCurdy, Michael T.
    Ostermann, Marlies
    Young, Paul J.
    Handisides, Damian R.
    Chawla, Lakhmir S.
    Tidmarsh, George F.
    Albertson, Timothy E.
    [J]. CRITICAL CARE, 2020, 24 (01):
  • [4] Angiotensin in cardiac surgery: efficacy in patients on angiotensin converting enzyme inhibitors
    Bennett, SR
    McKeown, J
    Drew, P
    Griffin, S
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (05) : 587 - 592
  • [5] Angiotensin II for the treatment of distributive shock in the intensive care unit: A US cost-effectiveness analysis
    Busse, Laurence W.
    Nicholson, Gina
    Nordyke, Robert J.
    Lee, Cho-Han
    Zeng, Feng
    Albertson, Timothy E.
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (02) : 145 - 151
  • [6] Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options
    Busse, Laurence W.
    Barker, Nicholas
    Petersen, Christopher
    [J]. CRITICAL CARE, 2020, 24 (01):
  • [7] Angiotensin II, tissue factor and the thrombotic paradox of hypertension
    Celi, Alessandro
    Cianchetti, Silvana
    Dell'Omo, Giulia
    Pedrinelli, Roberto
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2010, 8 (12) : 1723 - 1729
  • [8] Successful use of angiotensin II for vasoplegia after thoracoabdominal aortic aneurysm repair
    Chatterjee, Subhasis
    Preventza, Ourania
    Mousavi, Mariam C.
    Orozco-Sevilla, Vicente
    LeMaire, Scott A.
    Coselli, Joseph S.
    [J]. JTCVS TECHNIQUES, 2020, 4 : 72 - 75
  • [9] Angiotensin converting enzyme defects in shock: implications for future therapy
    Chawla, Lakhmir S.
    Chen, Steve
    Bellomo, Rinaldo
    Tidmarsh, George F.
    [J]. CRITICAL CARE, 2018, 22
  • [10] Treatment of Renin-Angiotensin-Aldosterone System Dysfunction With Angiotensin II in High-Renin Septic Shock
    Chow, Jonathan H.
    Wallis, Marianne
    Lankford, Allison S.
    Chancer, Zackary
    Barth, Rolf N.
    Scalea, Joseph R.
    LaMattina, John C.
    Mazzeffi, Michael A.
    McCurdy, Michael T.
    [J]. SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2021, 25 (01) : 67 - 73